Search Results - "Saltevo, J"

Refine Results
  1. 1

    Frequent pain in older people with and without diabetes - Finnish community based study by Karjalainen, M, Saltevo, J, Tiihonen, M, Haanpää, M, Kautiainen, H, Mäntyselkä, P

    Published in BMC geriatrics (15-03-2018)
    “…The association between pain and diabetes in older people has been largely unexplored. The aim of this survey was to analyze the prevalence and characteristics…”
    Get full text
    Journal Article
  2. 2

    Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study by Saltevo, J, Niskanen, Leo, Kautiainen, Hannu, Teittinen, Jorma, Oksa, Heikki, Korpi-Hyövälti, Eeva, Sundvall, Jouko, Männistö, Satu, Peltonen, Markku, Mäntyselkä, Pekka, Vanhala, Mauno

    Published in European journal of endocrinology (01-09-2011)
    “…BackgroundThe aim of this cross-sectional study was to examine the association between serum calcium and the components of metabolic syndrome (MetS).MethodsAs…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study by Saltevo, J., Vanhala, M., Kautiainen, H., Kumpusalo, E., Laakso, M.

    Published in Diabetic medicine (01-06-2008)
    “…Aims  We explored gender differences in the association of high‐sensitivity C‐reactive protein (hs‐CRP), interleukin‐1 receptor antagonist (IL‐1Ra) and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The association of adiponectin and low-grade inflammation with the course of metabolic syndrome by Ahonen, T.M, Saltevo, J.T, Kautiainen, H.J, Kumpusalo, E.A, Vanhala, M.J

    “…Abstract Background and aims Metabolic syndrome (MetS) is associated with low-grade inflammation. The connections of adiponectin and inflammatory cytokines…”
    Get full text
    Journal Article
  7. 7

    Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study by Saltevo, J., Laakso, M., Jokelainen, J., Keinänen-Kiukaanniemi, S., Kumpusalo, E., Vanhala, M.

    Published in Diabetes/metabolism research and reviews (01-07-2008)
    “…Background We evaluated the relationship of insulin sensitivity (assessed with the quantitative insulin sensitivity check index, QUICKI) to adiponectin and…”
    Get full text
    Journal Article
  8. 8

    Ageing and associations of fasting plasma glucose and 2 h plasma glucose with HbA(1C) in apparently healthy population. "FIN-D2D" study by Saltevo, J T, Kautiainen, H, Niskanen, L, Oksa, H, Puolijoki, H, Sundvall, J, Keinänen-Kiukaanniemi, S, Peltonen, M, Tuomilehto, J, Uusitupa, M, Mäntyselkä, P, Vanhala, M J

    Published in Diabetes research and clinical practice (01-09-2011)
    “…In this FIN-D2D cross-sectional survey the relationship of age with HbA(1c) and fasting and 2h glucose in the oral glucose tolerance test (OGTT) was explored…”
    Get full text
    Journal Article
  9. 9

    Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women - the FIN-D2D survey by Tuomilehto, H, Peltonen, M, Partinen, M, Seppä, J, Saaristo, T, Korpi-Hyövälti, E, Oksa, H, Saltevo, J, Puolijoki, H, Vanhala, M, Tuomilehto, J

    Published in Diabetes, obesity & metabolism (01-06-2008)
    “…To determine the association between sleep-disordered breathing (SDB) and obesity, diabetes and glucose intolerance among middle-aged men and women in Finland…”
    Get full text
    Journal Article
  10. 10

    Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes by Juurinen, L., Tiikkainen, M., Saltevo, J., Nikkilä, K., Lanki, H., Leppävuori, E., Kock, T., Teikari-Myyrä, T., Kauppinen-Mäkelin, R., Kotronen, A., Yki-Järvinen, H.

    Published in Diabetic medicine (01-04-2009)
    “…Aims  To compare the effect of adding nateglinide or placebo on postprandial glucose excursions (PPGEs), glycated haemoglobin (HbA1c), diurnal glucose profiles…”
    Get full text
    Journal Article
  11. 11

    Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes by EBELING, P, TEPPO, A.-M, KOISTINEN, H. A, VIIKARI, J, RÖNNEMAA, T, NISSEN, M, BERGKULLA, S, SALMELA, P, SALTEVO, J, KOIVISTO, V. A

    Published in Diabetologia (01-12-1999)
    “…Inflammation could play a part in insulin resistance. Thiazolidinediones, new antidiabetic drugs, possess anti-inflammatory effects in vitro. We investigated…”
    Get full text
    Journal Article
  12. 12

    Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy by Saltevo, J., Puolakka, J., Ylikorkala, O.

    Published in Diabetes, obesity & metabolism (01-10-2000)
    “…SUMMARY Aim  Type 2 diabetes and metabolic syndrome are major cardiovascular risk factors in postmenopausal women, but the role of vasoconstrictive…”
    Get full text
    Journal Article
  13. 13

    Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study by Tikkanen, M J, Laakso, M, Ilmonen, M, Helve, E, Kaarsalo, E, Kilkki, E, Saltevo, J

    Published in Diabetes care (01-04-1998)
    “…Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study. M J…”
    Get full text
    Journal Article
  14. 14

    A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes by van Zuydam, Natalie R, Ahlqvist, Emma, Sandholm, Niina, Deshmukh, Harshal, Rayner, N William, Abdalla, Moustafa, Ladenvall, Claes, Ziemek, Daniel, Fauman, Eric, Robertson, Neil R, McKeigue, Paul M, Valo, Erkka, Forsblom, Carol, Harjutsalo, Valma, Perna, Annalisa, Rurali, Erica, Marcovecchio, M Loredana, Igo, Jr, Robert P, Salem, Rany M, Perico, Norberto, Lajer, Maria, Käräjämäki, Annemari, Imamura, Minako, Kubo, Michiaki, Takahashi, Atsushi, Sim, Xueling, Liu, Jianjun, van Dam, Rob M, Jiang, Guozhi, Tam, Claudia H T, Luk, Andrea O Y, Lee, Heung Man, Lim, Cadmon K P, Szeto, Cheuk Chun, So, Wing Yee, Chan, Juliana C N, Ang, Su Fen, Dorajoo, Rajkumar, Wang, Ling, Clara, Tan Si Hua, McKnight, Amy-Jayne, Duffy, Seamus, Pezzolesi, Marcus G, Marre, Michel, Gyorgy, Beata, Hadjadj, Samy, Hiraki, Linda T, Ahluwalia, Tarunveer S, Almgren, Peter, Schulz, Christina-Alexandra, Orho-Melander, Marju, Linneberg, Allan, Christensen, Cramer, Witte, Daniel R, Grarup, Niels, Brandslund, Ivan, Melander, Olle, Paterson, Andrew D, Tregouet, David, Maxwell, Alexander P, Lim, Su Chi, Ma, Ronald C W, Tai, E Shyong, Maeda, Shiro, Lyssenko, Valeriya, Tuomi, Tiinamaija, Krolewski, Andrzej S, Rich, Stephen S, Hirschhorn, Joel N, Florez, Jose C, Dunger, David, Pedersen, Oluf, Hansen, Torben, Rossing, Peter, Remuzzi, Giuseppe, Brosnan, Mary Julia, Palmer, Colin N A, Groop, Per-Henrik, Colhoun, Helen M, Groop, Leif C, McCarthy, Mark I

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the…”
    Get full text
    Journal Article
  15. 15

    Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial by Mathieu, Chantal, Phillip, Moshe, Griffen, Steven C, Tschöpe, Diethelm, Thorén, Fredrik, Langkilde, Anna Maria, Proietto, Joseph, Stranks, Stephen, Chen, Roger, Pape, Alexia, Forbes, Mark, Morbey, Claire, Schnack, Christoph, Fliesser-Goerzer, Evelyn, Hoelzl, Bertram, Prager, Rudolf, Vercammen, Chris, Mathieu, Chantal, Ruige, Johannes, Woo, Vincent, St-Pierre, Bruno, Hramiak, Irene, Krarup Hansen, Troels, Gram, Jeppe, Saltevo, Juha, Taurio, Jyrki, Nieminen, Sakari, Pietilainen, Kirsi, Hadjadj, Samy, Cariou, Bertrand, Borot, Sophie, Tschoepe, Diethelm, Marck, Cornelia, Horacek, Thomas, Rose, Ludger, Goebel, Rolf, Kerenyi, Zsuzsanna, Oroszlan, Tamas, Konyves, Laszlo, Phillip, Moshe, Mosenzon, Ofri, Shehadeh, Naim, Adawi, Faiad, Wainstein, Julio, Dotta, Francesco, Genovese, Stefano, Di Bartolo, Paolo, Mannucci, Edoardo, Lapolla, Annunziata, Esteban, Alberto, Ruiz, Bazzoni, Ramirez, Guillermo Mondragon, Pelayo Orozco, Emilia, Medina Pech, Carlos, Sauque Reyna, Leobardo, Llamas Esperon, Guillermo, Nevarez Ruiz, Luis Alejandro, Vidrio Velazquez, Maricela, Garcia-Hernandez, Pedro Alberto, Araujo-Silva, Roberto, Villeda - Espinosa, Efrain, Popescu, Daniela, Constantin, Ciprian, Popa, Bogdan, Timar, Romulus, Pintilei, Ella, Gimenez, Margarita, Mezquita, Pedro, Eriksson, Jan, Londahl, Magnus, Eliasson, Bjorn, Gunstone, Anthony, Heller, Simon, Darzy, Ken, Mansell, Peter, Davies, Melanie, Courtney, Hamish, Turner, Wayne, Blagden, Mark, McCrimmon, Rory, Lane, Wendy, Lucas, Kathryn, White, Judith, Jantzi, Curtis, Ervin, William, Cleland, Alan, Fink, Raymond, Rodbard, Helena, Nakhle, Samer, Bays, Harold, Kane, Laurie, Ipp, Eli, Garg, Satish, Bhargava, Anuj, Rosenstock, Julio, Young, Laura, Aroda, Vanita, Pettus, Jeremy, Liljenquist, David, Dandona, Paresh

    Published in The lancet. Diabetes & endocrinology (01-11-2017)
    “…Dapagliflozin is a sodium-glucose cotransporter-2 inhibitor approved for the treatment of type 2 diabetes. We aimed to assess the efficacy and safety of…”
    Get full text
    Journal Article Web Resource
  16. 16
  17. 17

    Complications of nephropathia epidemica: three cases by Forslund, T, Saltevo, J, Anttinen, J, Auvinen, S, Brummer-Korvenkontio, M, Korhonen, A, Poutiainen, M

    Published in Journal of internal medicine (01-07-1992)
    “…Haemorrhagic fever with renal syndrome (HFRS) in Scandinavia is called nephropathia epidemica (NE), and is caused by the Puumala-virus, which belongs to the…”
    Get more information
    Journal Article
  18. 18

    Serum Omega-6 Polyunsaturated Fatty Acids and the Metabolic Syndrome: A Longitudinal Population-based Cohort Study by VANHALA, Mauno, SALTEVO, Juha, SOININEN, Pasi, KAUTIAINEN, Hannu, KANGAS, Antti J, ALA-KORPELA, Mika, MÄNTYSELKÄ, Pekka

    Published in American journal of epidemiology (01-08-2012)
    “…The serum fatty acid composition reflects the dietary fatty acid composition from the past few days to several weeks. However, the role of serum omega-3 (from…”
    Get full text
    Journal Article
  19. 19

    No correlation between carotid intima-media thickness and long-term glycemic control in individuals with type 1 diabetes by Inkeri, Jussi, Harjutsalo, Valma, Martola, Juha, Putaala, Jukka, Groop, Per-Henrik, Gordin, Daniel, Thorn, Lena M.

    Published in Acta diabetologica (01-04-2024)
    “…Aims To determine whether carotid intima-media thickness (CIMT), a surrogate marker of cardiovascular disease (CVD), is associated with long-term blood glucose…”
    Get full text
    Journal Article
  20. 20

    Single-nucleotide polymorphisms may cause erroneous results in primer-introduced restriction enzyme analyses:a case of molecular misdiagnosis of homozygous vs heterozygous familial hypercholesterolemia by Vuorio, AF, Paulin, L, Saltevo, J, Kontula, K

    Published in Molecular and cellular probes (01-12-1999)
    “…PCR amplification followed by a primer introduced restriction analysis PCR (PIRA-PCR) is a widely used method to detect point mutations. Usually the artificial…”
    Get full text
    Journal Article